|
Sort By
Time | Code | Name
|
|
| Release Time |
Code |
Stock Name |
Document (Hide Headline) |
| 15/01/2026 06:40 |
03759 |
PHARMARON |
Announcements and Notices
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section (1KB, HTM)
|
| 15/01/2026 06:30 |
03759 |
PHARMARON |
Announcements and Notices - (Issue of Shares under a General Mandate/Placing)
PLACING OF NEW H SHARES UNDER GENERAL ISSUANCE MANDATE (142KB, PDF)
|
| 15/01/2026 06:09 |
01495 |
JIYI HOLDINGS |
Announcements and Notices - (Discloseable Transaction/Suspension )
CLARIFICATION AND SUPPLEMENTAL ANNOUNCEMENT
IN RELATION TO
THE DISCLOSEABLE TRANSACTION IN RESPECT OF
THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL OF
A WHOLLY-OWNED SUBSIDIARY (54KB, PDF)
|
| 14/01/2026 22:59 |
03788 |
CHINA HANKING |
Announcements and Notices
INSIDE INFORMATION - STRATEGIC CHANGES OF HANKING GOLD (7349KB, PDF)
|
| 14/01/2026 22:58 |
03788 |
CHINA HANKING |
Announcements and Notices - (Change of Company Name)
PROPOSED CHANGE OF COMPANY NAME (58KB, PDF)
|
| 14/01/2026 22:58 |
02268 |
WUXI XDC |
Announcements and Notices
INSIDE INFORMATION
PRESENTATION AT 2026 ANNUAL HEALTHCARE CONFERENCE (7891KB, PDF)
|
| 14/01/2026 22:57 |
03788 |
CHINA HANKING |
Announcements and Notices
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (49KB, PDF)
|
| 14/01/2026 22:57 |
03788 |
CHINA HANKING |
Announcements and Notices - (Change in Directors or of Important Executive Functions or Resposnibilities/Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK/Change in Company Secretary)
(1) RESIGNATION OF EXECUTIVE DIRECTORS, CHIEF EXECUTIVE
OFFICER, PRESIDENT AND CHAIRMAN OF THE BOARD;
(2) APPOINTMENT OF CHIEF EXECUTIVE OFFICER, PRESIDENT
AND CHAIRMAN OF THE BOARD;
(3) APPOINTMENT OF EXECUTIVE DIRECTORS;
(4) CHANGES OF JOINT COMPANY SECRETARIES,
AUTHORISED REPRESENTATIVES AND PROCESS AGENT &
WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND
8.17 OF THE LISTING RULES; AND
(5) CHANGES OF THE BOARD COMMITTEE COMPOSITION (79KB, PDF)
|
| 14/01/2026 22:57 |
02269 |
WUXI BIO |
Announcements and Notices - (Discloseable Transaction)
Joint Announcement (285KB, PDF)
|
| 14/01/2026 22:56 |
02268 |
WUXI XDC |
Announcements and Notices - (Major Transaction/Announcement by Offeror pursuant to Takeovers Code)
JOINT ANNOUNCEMENT
(1) VOLUNTARY CONDITIONAL CASH OFFERS BY
CITIGROUP GLOBAL MARKETS ASIA LIMITED FOR AND
ON BEHALF OF THE OFFEROR FOR ALL THE ISSUED SHARES OF
THE COMPANY (OTHER THAN THOSE SHARES ALREADY OWNED
OR AGREED TO BE ACQUIRED BY THE OFFEROR AND THE
OFFEROR CONCERT PARTIES) AND TO CANCEL
ALL OUTSTANDING SHARE OPTIONS;
(2) IRREVOCABLE UNDERTAKINGS;
(3) POSSIBLE MAJOR TRANSACTION FOR THE OFFEROR;
(4) POSSIBLE DISCLOSEABLE TRANSACTION FOR
WUXI BIOLOGICS;
AND
(5) RESUMPTION OF TRADING (285KB, PDF)
|
| 14/01/2026 22:52 |
01875 |
BIODLINK-B |
Announcements and Notices - (Announcement by Offeree pursuant to Takeovers Code/Resumption)
JOINT ANNOUNCEMENT (1) VOLUNTARY CONDITIONAL CASH OFFERS BY
CITIGROUP GLOBAL MARKETS ASIA LIMITED FOR AND
ON BEHALF OF THE OFFEROR FOR ALL THE ISSUED SHARES OF
THE COMPANY (OTHER THAN THOSE SHARES ALREADY OWNED
OR AGREED TO BE ACQUIRED BY THE OFFEROR AND THE
OFFEROR CONCERT PARTIES) AND TO CANCEL
ALL OUTSTANDING SHARE OPTIONS;
(2) IRREVOCABLE UNDERTAKINGS;
(3) POSSIBLE MAJOR TRANSACTION FOR THE OFFEROR;
(4) POSSIBLE DISCLOSEABLE TRANSACTION FOR
WUXI BIOLOGICS;
AND
(5) RESUMPTION OF TRADING (285KB, PDF)
|
| 14/01/2026 22:50 |
02268 |
WUXI XDC |
Announcements and Notices - (Profit Warning)
POSITIVE PROFIT ALERT (60KB, PDF)
|
| 14/01/2026 22:46 |
01592 |
ANCHORSTONE |
Announcements and Notices - (Connected Transaction/Capital Reorganisation/Rights Issue)
(1) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL; (2) PROPOSED RIGHTS ISSUE ON THE BASIS OF FOUR (4) RIGHTS SHARES FOR EVERY ONE (1) EXISTING SHARE HELD ON THE RECORD DATE ON A NON-UNDERWRITTEN BASIS; AND (3) CONNECTED TRANSACTION IN RELATION TO THE SET-OFF ARRANGEMENT (307KB, PDF)
|
| 14/01/2026 22:45 |
02013 |
WEIMOB INC |
Announcements and Notices - (Issue of Shares under a General Mandate/Placing)
EXTENSION OF THE LONG STOP DATE
AND
UPDATE ON SECOND TRANCHE SUBSCRIPTION (62KB, PDF)
|
| 14/01/2026 22:45 |
09887 |
LEADS BIOLABS-B |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT- LBL-024 (OPAMTISTOMIG, PD-L1/4-1BB BISPECIFIC ANTIBODY) GRANTED FAST TRACK DESIGNATION BY THE U.S. FDA (58KB, PDF)
|
| 14/01/2026 22:41 |
02899 |
ZIJIN MINING |
Announcements and Notices
Terms of Reference of the Nomination and Remuneration Committee of the Board of Directors (187KB, PDF)
|
| 14/01/2026 22:39 |
02899 |
ZIJIN MINING |
Announcements and Notices
Terms of Reference of the Audit and Supervision Committee of the Board of Directors (185KB, PDF)
|
| 14/01/2026 22:32 |
01354 |
KINGFARPROPERTY |
Announcements and Notices - (Notice of EGM/SGM/Closure of Books or Change of Book Closure Period)
NOTICE OF EXTRAORDINARY GENERAL MEETING (73KB, PDF)
|
| 14/01/2026 22:30 |
02509 |
QYUNS-B |
Announcements and Notices
VOLUNTARY ANNOUNCEMENT
QX030N/CLD-423 ACHIEVED FIRST SUBJECTS DOSING IN
PHASE I CLINICAL TRIAL
CALDERA THERAPEUTICS SECURED CUMULATIVE FUNDING OF
US$112.5 MILLION (54KB, PDF)
|
| 14/01/2026 22:29 |
01354 |
KINGFARPROPERTY |
Circulars - (Connected Transaction/Major Transaction)
(1) MAJOR AND CONNECTED TRANSACTIONS IN RELATION TO THE
ACQUISITION AND LEASE OF PROPERTIES AND CARPARK SPACES;
(2) NOTICE OF THE EXTRAORDINARY GENERAL MEETING; AND
(3) CLOSURE OF REGISTER OF MEMBERS (687KB, PDF)
|
